Ricardo D Enriz
Overview
Explore the profile of Ricardo D Enriz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schiel A, Tosso R, Angelina E, Garcia A, Hennuyer N, Cortes D, et al.
J Chem Inf Model
. 2024 Dec;
65(1):298-311.
PMID: 39720903
We report here a new ligand for the peroxisome-proliferator-activated receptor type α (PPARα), an N-tosyl hydrazone benzopyran that was designed throughout the mapping of the polar zone of the binding...
2.
Gutierrez L, Persolja P, Tosso R, Zidar N, Kikelj D, Enriz R
RSC Med Chem
. 2024 Sep;
PMID: 39290385
We mapped the hydrophobic floor, an interesting subsite at the active site of DNA gyrase B (GyrB) from . We synthesized three new compounds with pendant groups targeting the hydrophobic...
3.
Zidar N, Cotman A, Sinnige W, Benek O, Barancokova M, Zega A, et al.
Bioorg Med Chem
. 2024 Jun;
109:117798.
PMID: 38906068
N-(Benzothiazole-2-yl)pyrrolamide DNA gyrase inhibitors with benzyl or phenethyl substituents attached to position 3 of the benzothiazole ring or to the carboxamide nitrogen atom were prepared and studied for their inhibition...
4.
Villarroel-Vicente C, Garcia A, Zibar K, Schiel M, Ferri J, Hennuyer N, et al.
Bioorg Med Chem Lett
. 2024 Apr;
106:129770.
PMID: 38677560
We have previously reported the total synthesis and structure-activity relationships (SAR) of 2-prenylated benzopyrans with PPAR agonist activity. Herein, we have described the synthesis and PPAR activity of 2-prenylated benzopyrans...
5.
Vettorazzi M, Diaz I, Angelina E, Salido S, Gutierrez L, Alvarez S, et al.
Bioorg Chem
. 2024 Jan;
144:107112.
PMID: 38237390
We report here the virtual screening design, synthesis and activity of eight new inhibitors of SphK1. For this study we used a pre-trained Graph Convolutional Network (GCN) combined with docking...
6.
Adarvez-Feresin C, Ortiz J, Pineiro M, Parravicini O, Enriz R, Garro A, et al.
Arch Pharm (Weinheim)
. 2024 Jan;
357(4):e2300581.
PMID: 38229212
This study aimed to evaluate the in silico and in vitro inhibitory effect of the combined use of galantamine (GAL) and donepezil (DON) against acetylcholinesterase and butyrylcholinesterase (BuChE) enzymes. In...
7.
Garcia A, Vila L, Duplan I, Schiel M, Enriz R, Hennuyer N, et al.
Eur J Med Chem
. 2024 Jan;
265:116125.
PMID: 38185055
Peroxisome proliferator-activated receptors (PPARs) play a major role in regulating inflammatory processes, and dual or pan-PPAR agonists with PPARγ partial activation have been recognised to be useful to manage both...
8.
Frigini E, Porasso R, Beke-Somfai T, Lopez Cascales J, Enriz R, Pantano S
J Chem Inf Model
. 2023 Oct;
63(21):6877-6889.
PMID: 37905818
Antimicrobial cationic peptides (AMPs) are excellent candidates for use as therapeutic antimicrobial agents. Among them, short peptides possessing sequences of 9-11 amino acids have some advantages over long-sequence peptides. However,...
9.
Funes M, Tosso R, Machado N, Fernandez M, Garro M, Diaz D, et al.
Fitoterapia
. 2023 Jul;
169:105622.
PMID: 37524126
New natural analgesic compounds that act in KORs are important alternatives for potential therapeutical use in medicine. In this work, we report and compare here the antinociceptive activity displayed by...
10.
Marques P, Villarroel-Vicente C, Collado A, Garcia A, Vila L, Duplan I, et al.
Pharmacol Res
. 2022 Dec;
187:106638.
PMID: 36586645
Background And Purpose: Selective peroxisome proliferator-activated receptors (PPARs) are widely used to treat metabolic complications; however, the limited effect of PPARα agonists on glucose metabolism and the adverse effects associated...